Montero A - Search Results

1

Managing chronic myeloid leukemia: a coordinated team care perspective.

Holloway S, Lord K, Bethelmie-Bryan B, Shepard MW, Neely J, McLemore M, Reddy SK, Montero A, Jonas WS, Gladney SP, Khanwani SL, Reddy SC, Lahiry AK, Heffner LT, Winton E, Arellano M, Khoury HJ. Holloway S, et al. Among authors: montero a. Clin Lymphoma Myeloma Leuk. 2012 Apr;12(2):88-93. doi: 10.1016/j.clml.2011.10.004. Epub 2011 Dec 8. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22154234 Review.

2

Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS, Leitman S, Read EJ, Childs R, Barrett AJ. Savani BN, et al. Among authors: montero a. Blood. 2006 Feb 15;107(4):1688-95. doi: 10.1182/blood-2005-05-1897. Epub 2005 Aug 30. Blood. 2006. PMID: 16131570 Free PMC article.

3

Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation.

Savani BN, Montero A, Kurlander R, Childs R, Hensel N, Barrett AJ. Savani BN, et al. Among authors: montero a. Bone Marrow Transplant. 2005 Dec;36(11):1009-15. doi: 10.1038/sj.bmt.1705167. Bone Marrow Transplant. 2005. PMID: 16205732

4

Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.

Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C, Childs R, Solomon S, Barrett AJ. Savani BN, et al. Among authors: montero a. Biol Blood Marrow Transplant. 2005 Mar;11(3):223-30. doi: 10.1016/j.bbmt.2004.12.328. Biol Blood Marrow Transplant. 2005. PMID: 15744241 Free article.

5

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

Solomon SR, Mielke S, Savani BN, Montero A, Wisch L, Childs R, Hensel N, Schindler J, Ghetie V, Leitman SF, Mai T, Carter CS, Kurlander R, Read EJ, Vitetta ES, Barrett AJ. Solomon SR, et al. Among authors: montero a. Blood. 2005 Aug 1;106(3):1123-9. doi: 10.1182/blood-2005-01-0393. Epub 2005 Apr 7. Blood. 2005. PMID: 15817673 Free PMC article. Clinical Trial.

6

Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.

Solomon SR, Savani BN, Childs R, Montero A, Boss C, Read EJ, Leitman SF, Barrett AJ. Solomon SR, et al. Among authors: montero a. Biol Blood Marrow Transplant. 2005 Aug;11(8):619-26. doi: 10.1016/j.bbmt.2005.05.004. Biol Blood Marrow Transplant. 2005. PMID: 16041312 Free article.

7

Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning.

Montero A, Savani BN, Kurlander R, Read EJ, Leitman SF, Childs R, Solomon SR, Barrett AJ. Montero A, et al. Br J Haematol. 2005 Sep;130(5):733-9. doi: 10.1111/j.1365-2141.2005.05665.x. Br J Haematol. 2005. PMID: 16115130 Free article.

8

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J, Keyvanfar K, Montero A, Hensel N, Kurlander R, Barrett AJ. Rezvani K, et al. Among authors: montero a. Blood. 2006 Aug 15;108(4):1291-7. doi: 10.1182/blood-2006-02-003996. Epub 2006 Apr 20. Blood. 2006. PMID: 16627754 Free PMC article. Clinical Trial.

9

Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.

Savani BN, Montero A, Srinivasan R, Singh A, Shenoy A, Mielke S, Rezvani K, Karimpour S, Childs R, Barrett AJ. Savani BN, et al. Among authors: montero a. Biol Blood Marrow Transplant. 2006 Dec;12(12):1261-9. doi: 10.1016/j.bbmt.2006.07.016. Biol Blood Marrow Transplant. 2006. PMID: 17162207 Free PMC article.

10

T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.

Montero A, Savani BN, Shenoy A, Read EJ, Carter CS, Leitman SF, Mielke S, Rezvani K, Childs R, Barrett AJ. Montero A, et al. Biol Blood Marrow Transplant. 2006 Dec;12(12):1318-25. doi: 10.1016/j.bbmt.2006.08.034. Biol Blood Marrow Transplant. 2006. PMID: 17162214 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

710 results

Search Page